Diagnostic home-testing company GetMyDNA disclosed on Friday that its COVID-19 DTC test kit is now available online as well as through bulk orders and retail purchase in time for the summer travel and employees return to work.
This test is available for order online at getmydna.com at USD99 a kit with free overnight shipping both ways, or for retailer/bulk purchase with customized solutions and pricing available, according to the company.
The company said its easy to read report is delivered the same day the lab receives the sample 99% of the time. All samples are processed in CLIA Certified and CAP Accredited full-service laboratory, Gravity Diagnostics.
The GetMyDNA COVID-19 Test Home Collection Kit DTC is an US FDA-authorised mail-in home collection test kit for COVID-19 and is available for individuals 18 years and older in all 50 US states. This test provides the gold-standard anterior nasal swab PCR test that can determine whether an asymptomatic or symptomatic individual is infected with COVID-19, concluded the company.
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
Precision Epigenomics partners with TruDiagnostic
Illumina's GRAIL divestment plan receives EC approval
Soligenix receives orphan drug designation from FDA for active ingredient in SuVax
Candel Therapeutics granted FDA Orphan Drug Designation for CAN-2409 in pancreatic cancer treatment
Lipogems completes patient enrolment in ARISE I US FDA IDE study
Amylyx Pharmaceuticals' AMX0035 shows promising impact on Wolfram syndrome symptoms
Ondine Biomedical's Steriwave approved for use by HCA UK
Roche attains CE Mark for first companion diagnostic for HER2-low metastatic breast cancer
Cadrenal Therapeutics' tecarfarin receives US FDA Orphan Drug Designation
BioCity Biopharma's BC2027 Phase one study IND application receives US FDA approval
Seres Therapeutics completes patient enrollment for SER-155 Phase 1B trial
Syros receives Fast Track Designation from FDA for tamibarotene in AML